Refine by
Epilepsy Treatment Suppliers & Manufacturers
4 companies found
based inGeneva, SWITZERLAND
Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available, small molecule drugs known as allosteric modulators for neurological disorders. Allosteric ...
Our partnered drug candidate, ADX71149 is a novel orally active mGlu2 PAM for the treatment of epilepsy. Our partner, Janssen Pharmaceuticals, Inc., or Janssen, a subsidiary of Johnson & Johnson is conducting ...
based inSollentuna, SWEDEN
Sensidose AB is a pharmaceutical company that has developed an innovative new system for individualized dosing of pharmaceutical tablets, allowing for fine-tuned, precision drug therapy. The system is composed of “micro”- tablets, sub-pharmaceutical ...
based inMinnetonka, MINNESOTA (USA)
Monteris Medical was founded in 1999 with the sole focus to help patients suffering from neurological diseases. The company’s goal remains: to create a minimally invasive surgical option for use in the brain. Monteris is a private equity backed ...
based inMississauga, ONTARIO (CANADA)
Award-winning, Clinical Stage/Life-Sciences company focused on the drug discovery and development of next-generation targeted therapeutics within the endocannabinoid system and specific brain receptors. The company is targeting anxiety, depression, ...
Mentanine®, supported by (cannabidiol “CBD” + IP formula) – molecules bond and synergistically attach to PPAR receptors allowing the formula to cross the blood-brain barrier (BBB) to target the central nervous ...